findmyKOL
Clinical trialNCT06484062RecruitingPhase 1Interventional

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

SponsorNational Cancer Institute (NCI)Enrollment54Acute Myeloid LeukemiaMyelodysplastic SyndromeMyelodysplastic Syndrome/Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale University

    New Haven, Connecticut, United States

    Maximilian Stahl
    Recruiting
  • Emory University Hospital/winship Cancer Institute

    Atlanta, Georgia, United States

    Michael J. Hochman
    Recruiting
  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

    Olatoyosi M. Odenike
    Recruiting
  • Uc Comprehensive Cancer Center at Silver Cross

    New Lenox, Illinois, United States

    Suspended
  • University of Chicago Medicine-Orland Park

    Orland Park, Illinois, United States

    Suspended
  • Uchicago Medicine Northwest Indiana

    Crown Point, Indiana, United States

    Suspended
  • University of Maryland/greenebaum Cancer Center

    Baltimore, Maryland, United States

    Vu H. Duong
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Evan C. Chen
    Recruiting
  • Siteman Cancer Center at Saint Peters Hospital

    City of Saint Peters, Missouri, United States

    Meagan Jacoby
    Recruiting
  • Siteman Cancer Center at West County Hospital

    Creve Coeur, Missouri, United States

    Meagan Jacoby
    Recruiting
  • Siteman Cancer Center at Christian Hospital

    St Louis, Missouri, United States

    Meagan Jacoby
    Recruiting
  • Siteman Cancer Center-South County

    St Louis, Missouri, United States

    Meagan Jacoby
    Recruiting
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Meagan Jacoby
    Recruiting
  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey, United States

    Tamanna Haque
    Recruiting
  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, United States

    Tamanna Haque
    Recruiting
  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey, United States

    Tamanna Haque
    Recruiting
  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

    Neil D. Palmisiano
    Recruiting
  • Memorial Sloan Kettering Commack

    Commack, New York, United States

    Tamanna Haque
    Recruiting
  • Memorial Sloan Kettering Westchester

    Harrison, New York, United States

    Tamanna Haque
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Tamanna Haque
    Recruiting
  • Memorial Sloan Kettering Nassau

    Uniondale, New York, United States

    Tamanna Haque
    Recruiting
  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, United States

    Madelyn Burkart
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Aug 2025
Primary completion
1 Jun 2028
Completion
1 Jun 2028
Last update posted
11 Jun 2026
Registered enrollment
54
Registry id
NCT06484062

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.